Sign In
Buy BGNE
$184.71
+0 (+0%)
At Close: Mar 28, 2025
IPO Update: iTeos Therapeutics Finalizes IPO Plan
01:31pm, Tuesday, 21'st Jul 2020
iTeos Therapeutics has filed to raise $151 million from an IPO of its common stock. The firm is developing treatments for solid tumors and other high prevalence cancer conditions.
BeiGene, Assembly Bio Ink $540M China HBV Deal; Shares Surge In Pre-Market
11:53am, Monday, 20'th Jul 2020
BeiGene (BGNE) and Assembly Biosciences (ASMB) have announced a new collaboration in China for Assembly’s three clinical-stage core inhibitor candidates for the treatment of chronic hepatitis B vi
\-- BeiGene acquires exclusive development and commercialization rights to ABI-H0731, ABI-H2158, and ABI-H3733 in China ---- Assembly receives $40 million upfront payment and is.
Week In Review: China Life Science Announces $5 Billion In Deals, A Weekly Record
06:23am, Sunday, 19'th Jul 2020
BeiGene, a Beijing oncology drug biopharma, announced a $2.1 billion private placement that will bring its cash holdings to almost $5.5 billion.
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
01:00pm, Friday, 17'th Jul 2020
BEIJING, China and CAMBRIDGE, Mass., July 17, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
Biotech Stock Roundup: GILD, MRNA Give Coronavirus Treatment Updates & More
02:31pm, Thursday, 16'th Jul 2020
The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.
BeiGene Announces Closing of Approximately $2.08 Billion Registered Direct Offering
09:00pm, Wednesday, 15'th Jul 2020
CAMBRIDGE, Mass. and BEIJING, China, July 15, 2020 -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and.
Why BeiGene Stock Jumped Today
07:43pm, Tuesday, 14'th Jul 2020
What happened Shares of BeiGene (NASDAQ: BGNE) were jumping 10.6% higher as of 3:09 p.m. EDT on Tuesday. The nice gain came after Bloomberg reported that Hillhouse Capital plans to buy $1 billion wort
BeiGene (BGNE) in Focus: Stock Moves 8.7% Higher
12:43pm, Tuesday, 14'th Jul 2020
BeiGene (BGNE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Hillhouse Plans to Invest $1 Billion In Beigene’s Share Sale
10:16am, Tuesday, 14'th Jul 2020
(Bloomberg) -- Hillhouse Capital plans to invest $1 billion in Chinese biotechnology company Beigene Ltd., said people with knowledge of the matter, in the largest equity financing ever by a biotech c
Why BeiGene's Stock Is Trading Higher Today
02:51pm, Monday, 13'th Jul 2020
BeiGene (NASDAQ: BGNE) shares are trading higher on Monday after Amgen announced a $421 million investment in the company.BeiGene is a clinical-stage biopharmaceutical company. It is engaged in the di
Amgen (AMGN) Invests Further in China-Based Oncology Partner
02:11pm, Monday, 13'th Jul 2020
Amgen (AMGN) announces additional investment of approximately $421 million in BeiGene. The companies have a collaboration for oncology products signed in 2019.
Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money
11:53am, Monday, 13'th Jul 2020
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Amgen Pours A Further $421M Into China’s BeiGene
10:40am, Monday, 13'th Jul 2020
Amgen (AMGN) has announced an additional investment of approximately $421 million in BeiGene’s (BGNE) registered direct offering of ordinary shares.This investment maintains Amgen’s current pro
BeiGene Plans $2B Direct Offering; Analyst Sees Further Upside Ahead
06:03am, Monday, 13'th Jul 2020
Chinese biotech BeiGene (BGNE) has announced the pricing of a registered direct offering of 145,838,979 ordinary shares, par value $0.0001 per share to certain existing investors.Each ordinary share i
